STANFORD, Calif. - A small clinical trial of a medication to treat kleptomania has failed to find any conclusive benefit for patients with the impulsive stealing disorder, according to researchers at the Stanford University School of Medicine.But the results leave open the possibility that some medications, including the one in the trial, may still be an effective treatment for certain patients.>>> Discuss This Story
